| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |